Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
F
|
FACC AG
SWB:1FC
|
AT |
|
Sasol Ltd
NYSE:SSL
|
ZA |
|
A
|
Atoss Software AG
SWB:AOF
|
DE |
|
S
|
Spectral Medical Inc
OTC:EDTXF
|
CA |
|
E
|
Eclipse Metals Ltd
ASX:EPM
|
AU |
|
A
|
Addus Homecare Corp
F:A41
|
US |
|
Z
|
Zen Corporation Group PCL
SET:ZEN
|
TH |
|
G
|
Genomictree Inc
KOSDAQ:228760
|
KR |
|
M
|
Mr DIY Group M Bhd
KLSE:MRDIY
|
MY |
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
C
|
Covista Inc
F:DVY
|
US |
|
Minebea Mitsumi Inc
F:MEA0
|
JP |
|
Sorrento Therapeutics Inc
OTC:SRNE
|
US |
|
Real Matters Inc
F:R3E
|
CA |
|
GS Holdings Ltd
SGX:43A
|
SG |
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
R
|
REV Group Inc
F:1RG
|
US |
|
Bytes Technology Group PLC
F:9NY
|
UK |
|
Murata Manufacturing Co Ltd
F:MUR
|
JP |
Bankruptcy Probability
Regeneron Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Regeneron Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
69.3T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Regeneron Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Regeneron Pharmaceuticals Inc has total debt of 2B USD. This includes both short-term (0 USD) and long-term (2B USD) debt.
You can find a full breakdown on its Balance Sheet.